InvestorsHub Logo
Followers 11
Posts 1565
Boards Moderated 0
Alias Born 09/19/2006

Re: None

Wednesday, 05/10/2017 11:08:20 AM

Wednesday, May 10, 2017 11:08:20 AM

Post# of 6389
Moffat, I am simply pointing out the market reaction to the conference call has not resulted in the normal run up on anticipation of news. The stock continues to trade near an over 3 1/2 year low. Nice work PN!

At a minimum PN needs to provide an update regarding the number of patients enrolled or who have been dosed to date in the stage 2 trial. Will he provide us with that information? If not, why is the real question. PN promised that 19 patients will be evaluated by year end. The shareholders have the right to know the progress in the number of enrollees to date but not the results.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BPTH News